Amneal Pharmaceuticals Inc - Company Profile
Powered by 
All the data and insights you need on Amneal Pharmaceuticals Inc in one report.
$295
- Save hours of research time and resources with
our up-to-date Amneal Pharmaceuticals Inc Strategy Report
- Understand Amneal Pharmaceuticals Inc position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
Related keylists
Amneal Pharmaceuticals Inc (Amneal) is a pharmaceutical company that develops, manufactures and distributes medicines. The company offers generic and specialty pharmaceutical products. Amneal offers products in various dosage forms comprising liquids, sterile injectables, oral solids, powders, nasal sprays, inhalation and respiratory products, transdermal patches, ophthalmics, films, and topicals. It sells its products to wholesalers, chain pharmacies, distributors, hospitals, and individual pharmacies. The company operates in the United States, India, and Ireland. It also operates in distribution centers situated in Pennsylvania, Fountain Run, Kentucky, and Philadelphia. The company has partnered with Baclofen Franchise, Puniska Healthcare Pvt. Ltd., Kashiv Specialty Pharmaceuticals, LLC, AvKARE, LLC and R&S Northeast LLC and others. Amneal is headquartered in Bridgewater, New Jersey, the US.
Headquarters
United States of America
Address
400 Crossing Boulevard, 3rd Floor, Bridgewater, New Jersey, 08807
Website
amneal.com
No of Employees
7,700
Industry
Pharmaceuticals and Healthcare
Ticker Symbol & Exchange
AMRX (NASD)
Revenue (2022)
$2.4B
8.2%
(2022 vs 2021)
EPS
XYZ
Net Income (2022)
XYZ
35.4%
(2022 vs 2021)
Market Cap*
$1.7B
Net Profit Margin (2022)
XYZ
40.3%
(2022 vs 2021)
* As of and is in US$
Amneal Pharmaceuticals Inc premium industry data and analytics
Products and Services
| Products | Brands |
|---|---|
| Specialty Products | Activella |
| Generics Products | Albenza |
| Activella (Estradiol/Norethindrone Acetate) | Dexedrine |
| XYZ | XYZ |
| XYZ | XYZ |
| XYZ | XYZ |
History
History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.
| Year | Event | Description |
|---|---|---|
| 2024 | Regulatory Approval | In March, the company secured approval from the U.S. Food and Drug Administration for ciprofloxacin and dexamethasone otic suspension. |
| 2024 | Contracts/Agreements | In February, the company entered into a partnership with Zambon Biotech to market IPX203 for the treatment of Parkinson's disease. |
| 2024 | New Products/Services | In January, the company introduced fluorometholone ophthalmic suspension. |
Competitor Comparison
| Key Parameters | Amneal Pharmaceuticals Inc | Pfizer Inc | AbbVie Inc | Gilead Sciences Inc | Viatris Inc |
|---|---|---|---|---|---|
| Headquarters | United States of America | United States of America | United States of America | United States of America | United States of America |
| City | Bridgewater | New York | North Chicago | Foster City | Canonsburg |
| State/Province | New Jersey | New York | Illinois | California | Pennsylvania |
| No. of Employees | 7,700 | 88,000 | 50,000 | 18,000 | 38,000 |
| Entity Type | Public | Public | Public | Public | Public |
Key Financial Charts
Sales Growth
Net Income Growth
Executives
| Name | Position | Board | Since | Age |
|---|---|---|---|---|
| Paul Meister | Chairman | Executive Board | 2019 | 70 |
| Chirag Patel | Co-Chief Executive Officer; Director; President | Executive Board | 2019 | 56 |
| Chintu Patel | Co-Chief Executive Officer; Director | Executive Board | 2019 | 51 |
| Tasos Konidaris | Executive Vice President; Chief Financial Officer | Senior Management | - | - |
| Jason B. Daly | Chief Legal Officer; Senior Vice President; Secretary - Corporate | Senior Management | 2022 | 49 |
| Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward